Reaction

Hypersplenism reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 487 reports · 9 co-occurring drugs

As of the last recalculation, Hypersplenism appears in 487 FAERS reports alongside 9 co-occurring drug terms. The strongest observed disproportionality signal is VOXELOTOR (PRR 174.1).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Voxelotor77174.1174.7
Hydroxyurea1939.940.0
Raltegravir1437.337.3
Deferasirox2135.335.4
Tenofovir Disoproxil Fumarate Tablets735.135.2
Cladribine731.631.6
Nevirapine628.828.8
Atazanavir927.327.3
Ritonavir 100 Mg926.226.2

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.